Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Resino

Showing results (231-240 of 418) with videos related to

Pageof 42
Sort By:
Frontiers in Immunology|January 1, 2025
Immune checkpoint proteins are associated with persistently high liver stiffness after successful HCV treatment in people with HIV: a retrospective studyRubén Martín-Escolano, Ana Virseda-Berdices, Juan Berenguer, et al.
Frontiers in Pharmacology|November 12, 2024
Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective studyRubén Martín-Escolano, Ana Virseda-Berdices, Juan Berenguer, et al.
Environmental Research|April 20, 2023
Environmental factors are associated to hospital outcomes in COVID-19 patients during lockdown and post-lockdown in 2020: A nationwide studyLaura Sánchez-de Prada, José María Eiros-Bachiller, Álvaro Tamayo-Velasco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2009
Rate and timing of hepatitis C virus relapse after a successful course of pegylated interferon plus ribavirin in HIV-infected and HIV-uninfected patientsJosé Medrano, Pablo Barreiro, Salvador Resino, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 22, 2023
Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV/HCV-coinfected patientsRubén Martín-Escolano, Ana Virseda-Berdices, Juan Berenguer, et al.
Biomolecules|April 12, 2019
Impact of <i>DARC</i> rs12075 Variants on Liver Fibrosis Progression in Patients with Chronic Hepatitis C: A Retrospective StudyMaría Ángeles Jiménez-Sousa, Ana Zaida Gómez-Moreno, Daniel Pineda-Tenor, et al.
Plos One|February 6, 2016
Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of OutcomeTeresa Aldámiz-Echevarría, Juan Berenguer, Pilar Miralles, et al.
Environmental Science & Technology|November 7, 2023
Exploring the Occurrence of Organic Contaminants in Human Semen through an Innovative LC-HRMS-Based Methodology Suitable for Target and Nontarget AnalysisElena Sánchez-Resino, Montse Marquès, Daniel Gutiérrez-Martín, et al.
The Pediatric Infectious Disease Journal|March 29, 2006
Low immunologic response to highly active antiretroviral therapy in naive vertically human immunodeficiency virus type 1-infected children with severe immunodeficiencySalvador Resino, Alejandro Alvaro-Meca, Maria Isabel de José, et al.
BMC Infectious Diseases|February 28, 2008
Immunological predictors of CD4+ T cell decline in antiretroviral treatment interruptionsElena Seoane, Salvador Resino, Santiago Moreno, et al.
Pageof 42

Showing results (231-240 of 418) with videos related to

Sort By:
Pageof 42
Frontiers in Immunology|January 1, 2025
Immune checkpoint proteins are associated with persistently high liver stiffness after successful HCV treatment in people with HIV: a retrospective studyRubén Martín-Escolano, Ana Virseda-Berdices, Juan Berenguer, et al.
Frontiers in Pharmacology|November 12, 2024
Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective studyRubén Martín-Escolano, Ana Virseda-Berdices, Juan Berenguer, et al.
Environmental Research|April 20, 2023
Environmental factors are associated to hospital outcomes in COVID-19 patients during lockdown and post-lockdown in 2020: A nationwide studyLaura Sánchez-de Prada, José María Eiros-Bachiller, Álvaro Tamayo-Velasco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2009
Rate and timing of hepatitis C virus relapse after a successful course of pegylated interferon plus ribavirin in HIV-infected and HIV-uninfected patientsJosé Medrano, Pablo Barreiro, Salvador Resino, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 22, 2023
Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV/HCV-coinfected patientsRubén Martín-Escolano, Ana Virseda-Berdices, Juan Berenguer, et al.
Biomolecules|April 12, 2019
Impact of <i>DARC</i> rs12075 Variants on Liver Fibrosis Progression in Patients with Chronic Hepatitis C: A Retrospective StudyMaría Ángeles Jiménez-Sousa, Ana Zaida Gómez-Moreno, Daniel Pineda-Tenor, et al.
Plos One|February 6, 2016
Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of OutcomeTeresa Aldámiz-Echevarría, Juan Berenguer, Pilar Miralles, et al.
Environmental Science & Technology|November 7, 2023
Exploring the Occurrence of Organic Contaminants in Human Semen through an Innovative LC-HRMS-Based Methodology Suitable for Target and Nontarget AnalysisElena Sánchez-Resino, Montse Marquès, Daniel Gutiérrez-Martín, et al.
The Pediatric Infectious Disease Journal|March 29, 2006
Low immunologic response to highly active antiretroviral therapy in naive vertically human immunodeficiency virus type 1-infected children with severe immunodeficiencySalvador Resino, Alejandro Alvaro-Meca, Maria Isabel de José, et al.
BMC Infectious Diseases|February 28, 2008
Immunological predictors of CD4+ T cell decline in antiretroviral treatment interruptionsElena Seoane, Salvador Resino, Santiago Moreno, et al.
Pageof 42